Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (941)
Vaxcyte, Inc. (PCVX)
Cowan Elvia — SVP, Finance&CAO
Shares
19,000
Price
$86.74
Total Value
$1.65M
Shares Held After
27,860
% of Holdings
40.5%
Vaxcyte, Inc. (PCVX)
Wassil Jim — EVP, Chief Scientific Ofc, COO
Shares
18,000
Price
$86.74
Total Value
$1.56M
Shares Held After
145,435
% of Holdings
11.0%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
235,477
Price
$27.13
Total Value
$6.39M
Shares Held After
0
% of Holdings
100.0%
Amylyx Pharmaceuticals, Inc. (AMLX)
MILNE GEORGE M JR — Director
Shares
30,000
Price
$27.70
Total Value
$830.90K
Shares Held After
782,881
% of Holdings
3.7%
SOPHiA GENETICS SA (SOPH)
Xu Zhenyu — Chief Scientific Officer
Shares
7,394
Price
$8.12
Total Value
$60.07K
Shares Held After
545,493
% of Holdings
1.3%
SOPHiA GENETICS SA (SOPH)
Muken Ross — Director
Shares
9,838
Price
$8.13
Total Value
$79.97K
Shares Held After
660,391
% of Holdings
1.5%
SOPHiA GENETICS SA (SOPH)
Menu Philippe — Chief Medical Officer
Shares
7,394
Price
$8.13
Total Value
$60.10K
Shares Held After
200,993
% of Holdings
3.5%
SOPHiA GENETICS SA (SOPH)
CARDOZA GEORGE — Chief Financial Officer
Shares
1,592
Price
$8.10
Total Value
$12.90K
Shares Held After
306,726
% of Holdings
0.5%
SOPHiA GENETICS SA (SOPH)
Camblong Jurgi — Director
Shares
40,172
Price
$8.13
Total Value
$326.53K
Shares Held After
3,395,650
% of Holdings
1.2%
SOPHiA GENETICS SA (SOPH)
Verma Abhimanyu — Chief Technology Officer
Shares
5,284
Price
$8.12
Total Value
$42.93K
Shares Held After
166,887
% of Holdings
3.1%
SOPHiA GENETICS SA (SOPH)
Puylaert Kevin — Chief Sales Officer
Shares
31
Price
$7.92
Total Value
$245.52
Shares Held After
147,732
% of Holdings
0.0%
SOPHiA GENETICS SA (SOPH)
Puylaert Kevin — Chief Sales Officer
Shares
185
Price
$8.06
Total Value
$1.49K
Shares Held After
147,763
% of Holdings
0.1%
SOPHiA GENETICS SA (SOPH)
Valente Manuela — Chief People Officer
Shares
4,240
Price
$8.13
Total Value
$34.49K
Shares Held After
206,210
% of Holdings
2.0%
SOPHiA GENETICS SA (SOPH)
Van Well Daan — Chief Legal Officer
Shares
6,168
Price
$8.12
Total Value
$50.10K
Shares Held After
332,716
% of Holdings
1.8%
Medline Inc. (MDLN)
GIC Private Ltd — 10% Owner
Shares
1,688,690
Price
$35.78
Total Value
$60.42M
Shares Held After
18,542,793
% of Holdings
8.3%
SI-BONE, Inc. (SIBN)
Maheshwari Anshul — Chief Op&Financial Officer
Shares
1,731
Price
$19.50
Total Value
$33.75K
Shares Held After
218,235
% of Holdings
0.8%
ImmunityBio, Inc. (IBRX)
Simon Barry J. — Director
Shares
25,000
Price
$10.75
Total Value
$268.76K
Shares Held After
2,777,788
% of Holdings
0.9%
BICYCLE THERAPEUTICS PLC (BCYC)
Lee Kevin — Director
Shares
1,638
Price
$3.57
Total Value
$5.85K
Shares Held After
595,866
% of Holdings
0.3%
BICYCLE THERAPEUTICS PLC (BCYC)
Skynner Michael — CHIEF SCIENTIFIC OFFICER
Shares
503
Price
$3.57
Total Value
$1.80K
Shares Held After
154,726
% of Holdings
0.3%
BICYCLE THERAPEUTICS PLC (BCYC)
Perry Jennifer Scott — Chief Operating Officer
Shares
326
Price
$3.78
Total Value
$1.23K
Shares Held After
89,552
% of Holdings
0.4%
BICYCLE THERAPEUTICS PLC (BCYC)
Perry Jennifer Scott — Chief Operating Officer
Shares
80
Price
$3.56
Total Value
$284.80
Shares Held After
89,878
% of Holdings
0.1%
BICYCLE THERAPEUTICS PLC (BCYC)
Hannay Michael Charles Ferguson — CHIEF PROD&SUPPLY CHAIN OFF
Shares
242
Price
$3.57
Total Value
$863.94
Shares Held After
92,561
% of Holdings
0.3%
CARLSMED, INC. (CARL)
Bertolini Jeffrey — Chief Operating Officer
Shares
747
Price
$14.39
Total Value
$10.75K
Shares Held After
22,489
% of Holdings
3.2%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
72,000
Price
$97.23
Total Value
$7.00M
Shares Held After
108,209
% of Holdings
40.0%
REPLIGEN CORP (RGEN)
Loeillot Olivier — Director
Shares
4,202
Price
$190.00
Total Value
$798.38K
Shares Held After
45,788
% of Holdings
8.4%
REPLIGEN CORP (RGEN)
Loeillot Olivier — Director
Shares
1,333
Price
$178.75
Total Value
$238.27K
Shares Held After
45,788
% of Holdings
2.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
360
Price
$546.63
Total Value
$196.79K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
920
Price
$545.69
Total Value
$502.04K
Shares Held After
324,803
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,260
Price
$544.59
Total Value
$686.19K
Shares Held After
325,723
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
783
Price
$543.54
Total Value
$425.59K
Shares Held After
326,983
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
918
Price
$542.56
Total Value
$498.07K
Shares Held After
327,766
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,239
Price
$541.66
Total Value
$671.12K
Shares Held After
328,684
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,028
Price
$540.50
Total Value
$555.63K
Shares Held After
329,923
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
931
Price
$539.50
Total Value
$502.28K
Shares Held After
330,951
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
655
Price
$538.62
Total Value
$352.80K
Shares Held After
331,882
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
905
Price
$537.43
Total Value
$486.37K
Shares Held After
332,537
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
501
Price
$536.26
Total Value
$268.67K
Shares Held After
333,442
% of Holdings
0.2%
BICYCLE THERAPEUTICS PLC (BCYC)
Thompson Travis Alvin — Chief Financial Officer
Shares
79
Price
$3.57
Total Value
$282.03
Shares Held After
64,449
% of Holdings
0.1%
Artiva Biotherapeutics, Inc. (ARTV)
Aslan Fred — Director
Shares
61,696
Price
$6.84
Total Value
$421.83K
Shares Held After
1,543,069
% of Holdings
3.8%
Artiva Biotherapeutics, Inc. (ARTV)
Banerjee Subhashis — Chief Medical Officer
Shares
1,099
Price
$6.84
Total Value
$7.51K
Shares Held After
169,848
% of Holdings
0.6%
Artiva Biotherapeutics, Inc. (ARTV)
Horan Christopher — Chief Tech Operations Officer
Shares
10,340
Price
$6.84
Total Value
$70.70K
Shares Held After
312,744
% of Holdings
3.2%
Artiva Biotherapeutics, Inc. (ARTV)
Bush Jennifer — COO, CLO, Compliance Officer
Shares
8,370
Price
$6.84
Total Value
$57.23K
Shares Held After
366,159
% of Holdings
2.2%
Monte Rosa Therapeutics, Inc. (GLUE)
Bowen Matthew — Principal Accounting Officer
Shares
13
Price
$10.56
Total Value
$137.28
Shares Held After
25,891
% of Holdings
0.1%
Anteris Technologies Global Corp. (AVR)
L1 Capital Pty Ltd — 10% Owner
Shares
648,455
Price
$7.51
Total Value
$4.87M
Shares Held After
12,778,380
% of Holdings
5.1%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
5,182
Price
$29.67
Total Value
$153.75K
Shares Held After
377,802
% of Holdings
1.4%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
6,699
Price
$28.82
Total Value
$193.07K
Shares Held After
382,984
% of Holdings
1.7%
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
Reynoso Jamie L. — CEO, Medicare Advantage
Shares
8,750
Price
$4.42
Total Value
$38.67K
Shares Held After
2,794,696
% of Holdings
0.3%
Grace Therapeutics, Inc. (GRCE)
Opaleye Management Inc. — 10% Owner
Shares
1,694
Price
$2.06
Total Value
$3.49K
Shares Held After
2,858,657
% of Holdings
0.1%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
18,182
Price
$1.33
Total Value
$24.18K
Shares Held After
935,021
% of Holdings
1.9%
Royalty Pharma plc (RPRX)
Urist Marshall — EVP, Research&Investments
Shares
4,126
Price
$57.10
Total Value
$235.59K
Shares Held After
0
% of Holdings
100.0%
941 transactions